9040:HK:HK-Global X MSCI China ETF (USD)

ETF | Others |

Last Closing

USD 4.232

Change

+0.01 (+0.24)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.02 (+0.09%)

USD 159.33B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

-0.04 (-0.05%)

USD 30.56B
2801:HK iShares Core MSCI China ETF

+0.08 (+0.34%)

USD 22.44B
2823:HK iShares FTSE A50 China

N/A

USD 17.65B
83188:HK ChinaAMC CSI 300 Index ETF

N/A

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.01 (+0.97%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.08 (+0.71%)

USD 9.22B
82822:HK CSOP FTSE China A50

-0.02 (-0.17%)

USD 8.59B
9010:HK iShares Core MSCI AC Asia ex J..

-0.19 (-2.58%)

USD 3.03B

ETFs Containing 9040:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.00% 80% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.00% 80% B- 75% C
Trailing 12 Months  
Capital Gain 39.21% 82% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.21% 80% B- 78% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.10% 79% B- 69% C-
Dividend Return 9.10% 78% C+ 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.47% 70% C- 87% B+
Risk Adjusted Return 62.86% 87% B+ 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike